Introduction
Immunohistochemical studies in the rat have shown that Gα i2 is specifically localized in tissues having motile cilia with a characteristic 9+2 ultrastructure. Such a specific localization in rat oviductal, tracheal and brain ependymal cilia (Shinohara et al., 1998) implies that Gα i2 may well serve a physiological function distinct from those of the other Gα subunits. It is probable that Gα i2 might play a cilia-specific physiological role. Interestingly, proteomic analysis has revealed Gα i2 as a resident axonemal protein of the human bronchial cilia (Ostrowski et al., 2002) . To date, however, there are no reports providing evidence of the localization of Gα i2 in any other human ciliated tissues, such as fallopian tubes. In this study, we identify the presence and localization of Gα i2 in tissues which are primarily in contact with gametes, and provide environment for fertilization, early development of the embryo as well as implantation, i.e., the human fallopian tube and endometrium. We have also evaluated the potential changes in Gα i2 expression in human endometrium during the menstrual cycle to reveal any potential hormonal regulation of this G protein subunit in humans. 
Materials and methods

Endometrial tissue collection and preparation for immunohistochemistery
The current study was approved by the Local Ethics Committee and informed written consent was obtained prior to the collection of tissue samples. For immunohistochemical investigations, tissue samples were obtained from 6 fertile women, and for genomic studies, endometrial biopsies were obtained from 21 fertile women. All the women taking part in the investigation had regular cycles, showed no evidence of any pathological uterine disorder, and had not used oral contraception or an intrauterine device during the previous three months.
Biopsies were obtained in the operating theatre between 2 and 29 days after the last menstrual period (LMP). The mean age of the women taking part in the study was 35 (range 24-40) years, and each had had at least one previous successful pregnancy.
Endometrial biopsies for immunohistochemistry were immediately snap-frozen and stored in liquid nitrogen until processed. Cryosections were cut at 5 µm and stored at -70°C until use.
For genomic studies, endometrial biopsies were immediately placed in RNAlater (Ambion, Huntingdon, U.K.), followed by immersion in liquid nitrogen until processed.
Fallopian tube tissue collection and preparation for immunohistochemistry
Human fallopian tube tissues were collected from 9 patients undergoing total abdominal hysterectomy for benign gynaecological conditions. The mean age of the women taking part in the study was 42 (range 33-56) years.
Fallopian tube tissue samples for immunohistochemistry were immediately fixed in 10% formalin overnight and embedded in paraffin. Paraffin sections were cut at 5 µm. For genomic studies, fallopian tube tissue samples were immediately placed in RNAlater (Ambion), and stored for 24 hours at 4°C followed by immersion and storage in liquid nitrogen until processed. 
RNA isolation and cDNA synthesis
Tissues were removed from RNAlater and homogenised in 3 ml of TRIreagent (SigmaAldrich) using an Ultra-Turrax homogenizer for 2 min. Total RNA from the tissues and temperatures of 58° (β-actin) and 65° (Gα i2 ) were used. All experiments included RT controls as well as negative controls (no cDNA). PCR products were separated on 1.2 % agarose gel.
Quantitative real time PCR
Quantitative real time PCR was performed with the constructed cDNAs and the same primers that were used in PCR reactions. SYBR Green Jump Start (Sigma-Aldrich) master mix (containing 10µl SYBR Green, 7µl Water, 1µl of each primer and 1µl cDNA) was added to each well of PCR plate and amplification was performed under the following conditions: 50 cycles (95° 30 sec, 58° or 65° 30 sec, 72° 30 sec). All experiments included RT controls and negative controls (no cDNA).
Results were analyzed using iCycler (Biorad laboratories Ltd, Hemel Hempstead, UK). To compare relative quantities of Gα i2 expression during the menstrual cycle, endometrial biopsies were divided into three groups; menstrual (LMP + 1-4 ; n = 3; LMP +1, +4 and +4), proliferative (LMP + 5-14 ; n = 9; early proliferative LMP +5, +5 and +7, mid-proliferative LMP +8, +9 and +10, late proliferative LMP +11, +12 and +13) and secretory (LMP + 15-29 ; n = 9; early secretory LMP +16, +16 and +17, mid-secretory LMP +20, +21 and +22, late secretory LMP +26, +28 and +29). Relative Gα i2 expression quantities were compared between these groups. The threshold cycle values were normalised against threshold value of human β-actin. The results were expressed as mean ± S.E.M. Statistical analysis was performed by using one-way ANOVA with Tukey's multiple comparison test. We used human fallopian tube tissue and human endometrial biopsies to study the expression of Gα i2 by PCR. Our data revealed that Gα i2 is expressed in human fallopian tube and human endometrium (Figure 1 A, B) . Our studies also confirmed that Gα i2 is expressed in primary cultures of fallopian tube epithelial cells (Figure 1 C) . Control experiments with non-reverse transcribed RNA of each sample confirmed that there was no contamination of human DNA in the samples.
Immunohistochemistry shows specific localization of Gα i2 protein in fallopian tube cilia and enrichment in endometrial glands.
Immunostaining on human fallopian tube paraffin sections showed specific localization of Gα i2 protein in fallopian tube epithelial cells and the cilia (Figure 2 C) . Positive staining was also seen in the cytoplasm of epithelial cells, surrounding the nuclei. In endometrial tissue, Gα i2 staining was enriched in endometrial glands, but was present also in stroma (Figure 2 A,   B) .
Quantitative real time PCR shows alterations in Gα i2 gene expression during the menstrual cycle.
We carried out quantitative real time PCR experiment on endometrial biopsies spanning the menstrual cycle (Figure 3) . Based on the phase of the menstrual cycle of each patient, the biopsies were designated in three groups, namely menstrual (LMP + 1-4), proliferative (LMP + 5-14) and secretory .
Our results demonstrated that endometrial expression of Gα i2 gene changed during the cycle.
The expression reached its peak in secretory phase. The expression of Gα i2 gene in secretory phase was significantly higher (p < 0.05) compared to that of the other phases. The presence of G protein subunit Gα i2 in rat myometrial membranes was first reported by Milligan et al. (1989) and the finding was later supported by a study suggesting differential regulation of Gα i2 and Gα i3 in rat myometrium during gestation (Tanfin et al., 1991) . In human myometrium, the levels of G protein subunits Gα i1 , Gα i3 , Gα q and Gα 11 have been shown to remain constant in pregnant and non-pregnant women, while levels of Gα i2 decrease during pregnancy. The simultaneous, substantial increase in myometrial G s suggested that the balance between Gα i2 and G s might be essential in regulating relaxation of the uterus during pregnancy (Europe-Finner et al., 1993) . Besides this, G i family proteins have been suggested to be functionally linked to α 2 adrenergic signalling in human myometrium during pregnancy (Breuiller et al., 1990) . Later studies in the rat have confirmed the involvement of Gα i2 and Gα i3 in α 2 /β 2 adrenergic signalling in the maintenance of uterus relaxation during rat pregnancy .
Unlike the thoroughly studied myometrium, the presence and role of Gα i2 in other regions of the reproductive tract has remained largely obscure. Although the presence of G i family proteins have been described in human endometrium during artificial cycles of hormone replacement therapy, those studies rely solely on data from immunoblotting, using an antibody unable to discriminate between the closely related Gα i1 and Gα i2 (Bernardini et al., 1995 (Bernardini et al., , 1999 . Therefore, prior to our study, cyclical changes in Gα i2 expression have not been reported in humans. Quantitative PCR showed that Gα i2 expression in human endometrium in vivo significantly increased towards secretory phase of the menstrual cycle. This suggested that sex hormones, like oestrogen or progesterone, might regulate the expression of this G i subunit in human endometrium. Furthermore, immunostaining clearly demonstrated the main localization of Gα i2 in endometrial glands and partially in endometrial stroma. It is likely that Gα i2 is hormonally regulated in the human endometrium. Earlier studies on rat myometrium have shown that estradiol administration during rat pregnancy increases the levels of both Gα i2 and Gα i2 mRNA, while progesterone has no effect on Gα i2 expression.
Instead, progesterone was reported to cause a decrease in Gα q subunit expression (CohenTannoudji et al., 1995) . Other studies in pregnant rat myometrium have suggested a regulatory role for progesterone in control of β 2 receptors (Maltier et al., 1989) and G s proteins (Elwardy-Merezak et al., 1994) , as well as in upregulation β 2 receptor expression (Vivat et al., 1992) . Apart from the studies by Bernardini et al. (1995; 1999) the potential role for sex hormones in regulation of G proteins in the human has remained largely unexplored.
In the present study, we have reported for the first time the localization of Gα i2 in fallopian tube epithelial cilia. In fallopian tubes, ciliary beat is essential for gamete transport in association with the tubal secretory flow and muscle contractility. Furthermore, fallopian tubes have been proposed to act as sperm reservoirs, where the ciliated epithelial cells interact with sperm (Baillie et al., 1997; Pacey et al., 1995a; Pacey et al., 1995b; Reeve et al., 2003) .
Fallopian tube epithelial cells have also been demonstrated to preserve the viability of sperm (Kervancioglu et al., 1994; Kervancioglu et al., 2000; Murray and Smith, 1997) . Given the fact that Gα i2 is specifically localized in rat tissue motile cilia with a characteristic 9+2 ultrastructure, namely in rat oviductal, tracheal and brain ependymal cilia (Shinohara et al., 1998) , it seems evident that this G i subunit might have a cilia-specific physiological role.
Apart from proteomic analysis providing evidence of Gα i2 as a resident axonemal protein of the human bronchial cilia (Ostrowski et al., 2002) , there are no reports describing Gα i2 in any other human ciliated tissue. In addition to positive immunostaining of fallopian tube cilia, we reported here positive immunostaining surrounding the nuclei. This presumably represents pre-stage Gα i2 which is still in synthesis, or alternatively, Gα i2 which is ready for transport into cilia by intraflagellar transport mechanisms. This intracellular machinery is vital for assembly and maintenance of the cilia, as it transports essential particles, such as proteins synthesised in the cytoplasm of cell, into the cilia, and returns the turnover products to the cytoplasm of cell (Rosenbaum and Witman, 2002) . subunit in immunological processes (Dalwadi et al., 2003; Fan et al., 2005; Han et al., 2005; Jiang et al., 1997; Zhang et al., 2005) . Gα i2 has been revealed to control regulation of T-cell proliferation (Zhang et al., 2005) and B cell development (Dalwadi et al., 2003) . Furthermore, Gα i2 has been suggested to mediate chemokine signalling (Han et al., 2005) . However, reports of Gα i2 -knockout studies have not provided any information on potential involvement of this G i subunit in modulation of mice fertility. Interestingly, a recent study on Gα i2 -knockout mice showed Gα i2 to differentially regulate inflammatory mediator production in response to microbial stimuli and proposed a TLR-signalling regulating, anti-inflammatory role for Gα i2 by an yet unknown mechanism (Fan et al., 2005) . Regarding the potential link between TLR-signalling and Gα i2 in female reproductive tract, it is noteworthy that our previous studies showing the localization pattern of several TLRs (Fazeli et al., 2005) showed a similar pattern of localisation compared to that we now report for Gα i2 . Future studies should be directed towards understanding whether Gα i2 might share signalling pathways with TLRs, and potentially have a TLR-signalling regulating role in human reproductive tract. 386   387   388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431 Milligan, G., Tanfin, Z., Goureau, O., Unson, C. and Harbon, S. (1989) 
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